FDA and NIH let clinical trial sponsors keep results secret and break the law | Science | AAAS
Julie Mathena - Director, Global Medical Affairs - Teva Pharmaceuticals | LinkedIn
Teva takes 2nd long-acting schizophrenia drug into phase 3
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Definitive Proxy Statement
Insilico collaborates with Teva on AI system | EurekAlert!
Teva clinical trial transparency and disclosure policy - July 8, 2019
Reslizumab Reslizumab (Teva) | Bioz | Ratings For Life-Science Research
Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan | International Business
Regeneron and Teva Face FDA Hold On Chronic Pain Clinical Trial - Xtalks
2020 Clinical Trials in Canada - An Overview | Clinical Trial Design and Statistical Analysis experts
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business